News

Filter

Current filters:

CrestorPatents

1 to 9 of 12 results

Further savings expected following Australian Crestor patent decision, says GMiA

07-03-2013

In a decision brought down by the Australian Federal Court earlier this week, suppliers of generic medicines…

Asia-PacificAstraZenecaCardio-vascularCrestorGenericsPatentsPharmaceuticalPricing

AstraZeneca's Crestor patent rule invalid in Australia

05-03-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed this morning that the Federal Court of Australia…

Asia-PacificAstraZenecaCardio-vascularCrestorPatentsPharmaceutical

AstraZeneca sees 3rd-qtr 2010 earnings slump 27%, hit by charges and generic competition; sues Watson

28-10-2010

Generic competition, as well as restructuring and legal costs have taken a hefty toll on AstraZeneca’s…

AstraZenecaCrestorFinancialPatentsPharmaceuticalWatson Pharmaceuticals

Tough road ahead for some generics after USA’s Federal Circuit Patent Use Code decisions

07-09-2010

A recent report issued by Morgan Stanley, titled Pharmaceuticals - Potential Selective Upside for Industry…

AstraZenecaCaraco PharmaceuticalCrestorLegalNorth AmericaNovo NordiskPatentsPharmaceuticalPrandin

1 to 9 of 12 results

COMPANY SPOTLIGHT

Menarini

Back to top